- Home
- APVO vs AEMD Comparison
APVO vs AEMD Comparison
Compare APVO & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- AEMD
- Stock Information
- Founded
- APVO 2016
- AEMD 1984
- Country
- APVO United States
- AEMD United States
- Employees
- APVO N/A
- AEMD N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- AEMD Medical/Dental Instruments
- Sector
- APVO Health Care
- AEMD Health Care
- Exchange
- APVO Nasdaq
- AEMD Nasdaq
- Market Cap
- APVO 4.1M
- AEMD 4.1M
- IPO Year
- APVO N/A
- AEMD N/A
- Fundamental
- Price
- APVO $3.23
- AEMD $1.22
- Analyst Decision
- APVO Strong Buy
- AEMD Strong Buy
- Analyst Count
- APVO 1
- AEMD 1
- Target Price
- APVO $5,920.00
- AEMD $56.00
- AVG Volume (30 Days)
- APVO 6.6M
- AEMD 265.2K
- Earning Date
- APVO 08-07-2025
- AEMD 06-26-2025
- Dividend Yield
- APVO N/A
- AEMD N/A
- EPS Growth
- APVO N/A
- AEMD N/A
- EPS
- APVO N/A
- AEMD N/A
- Revenue
- APVO N/A
- AEMD N/A
- Revenue This Year
- APVO N/A
- AEMD N/A
- Revenue Next Year
- APVO N/A
- AEMD N/A
- P/E Ratio
- APVO N/A
- AEMD N/A
- Revenue Growth
- APVO N/A
- AEMD N/A
- 52 Week Low
- APVO $2.81
- AEMD $1.20
- 52 Week High
- APVO $485.37
- AEMD $8.44
- Technical
- Relative Strength Index (RSI)
- APVO 34.28
- AEMD 41.34
- Support Level
- APVO $2.81
- AEMD $1.40
- Resistance Level
- APVO $13.11
- AEMD $2.88
- Average True Range (ATR)
- APVO 1.10
- AEMD 0.26
- MACD
- APVO 0.30
- AEMD -0.02
- Stochastic Oscillator
- APVO 4.08
- AEMD 36.49
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.